Definitive Contract 75N95022C00029

This federal contract award was made by the National Institute on Aging, a component of the Department of Health and Human Services, to Vesicle Therapeutics Inc., a small business biotechnology company. The $475,152 firm-fixed-price contract, which has a period of performance from September 2022 to September 2024, is for the development of neurotropic gectosomes as a central nervous system gene delivery system for Alzheimer's disease and Alzheimer's disease-related dementias therapy development....

The National Institute on Aging (NIA), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded an $852,000 firm fixed price delivery order contract to The Bioteam, Inc. (Bioteam) under the company's Multiple Award Schedule contract vehicle. Bioteam will perform an Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Data Ecosystem Landscape Assessment for NIA through November 15, 2023 from its place of performance...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000 definitive contract to Antagen Biosciences Inc., doing business as Antagen Pharmaceuticals, as part of the Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from July 5, 2022 through November 30, 2023 to be performed in Canton, Massachusetts. The award is set aside for...

This is a $244,800 contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to RPK Associates, LLC, a small business. The contract is for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products for NIH drug discovery and development programs, including the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics)...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $349,999.39 firm fixed price contract to Invivosciences, Inc. Biotech Toxicology, Human Tissue, Precison Drug Division under the Small Business Innovation Research Program Phase I Action. The contract is for the development of mechanism-based adult stem cell treatments to combat aging pathologies and will be performed in Madison, Wisconsin over a one year period ending August 31,...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Aphios Corp, a minority-owned for-profit organization, for the development of "CRITICAL FLUID NANOSOMES FOR EFFECTIVE TARGETED DELIVERY AND MANUFACTURE OF SIRNA-BASED THERAPEUTICS." The firm-fixed-price contract has a potential value of $299,591.00 and a completion date of...

This is a $2,898,257 SBIR Phase I contract awarded by the National Institute on Aging (NIA) to Seabright LLC, a small disadvantaged woman-owned business located in Seattle, WA. The contract is for research and development of "technology to facilitate characterization of the exposome in under-resourced populations for AD/ADRD studies." The contract was awarded under the NIA's SBIR program, which aims to stimulate innovation and strengthen the role of small businesses in meeting...

This $500,000 firm fixed price contract was awarded by the National Institutes of Health National Institute on Aging to Neucyte Inc. to conduct research and development in support of a Phase I Small Business Innovation Research project. The contract calls for Neucyte to develop a miniaturized automated drug screening platform to support the NIH's mission of advancing biomedical research on aging. The work will be performed in Mountain View, California over a one year period beginning in November...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Lifesensors Inc., doing business as Gene Transcription TECH. The contract is for applied/exploratory biomedical research, with a ceiling value of $149,550 and a period of performance through March 30, 2010. Lifesensors is a biotechnology company that conducts research on novel therapeutic approaches such as targeted...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $3 million firm fixed price purchase order to Oxford Nanopore Technologies Inc., a division of Oxford Nanopore Technologies PLC, to provide long read sequencing kits to the Laboratory of Neurogenetics for neurodegenerative disease research. The two month contract will support the laboratory's efforts to advance understanding of conditions such as Alzheimer's and Parkinson's diseases....